Box score
NewcelX Ltd.
Reported $7.2M sold in a new Form D filed October 21, 2024 (Kloten, outside the US).
- Biggest raise
- $7.2M filed Oct 21, 2024
- League
- Bio & Health Biotechnology
- Based in
- Kloten, outside the US
- Season rank
- #419 of 1,389 in the Bio & Health League; #2540 of 12,443 overall (2024)
- Entity
- Other
Form D filings since 2024 8
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-08-24 | New notice | $2.9M | $2.9M | SEC |
| 2026-05-13 | New notice | $3.4M | $3.4M | SEC |
| 2025-07-10 | New notice | $1M | $1M | SEC |
| 2025-04-14 | New notice | $2M | $2M | SEC |
| 2025-01-22 | New notice | $500K | $500K | SEC |
| 2024-10-21 | New notice | $7.2M | $7.2M | SEC |
| 2024-07-15 | New notice | $787K | $787K | SEC |
| 2024-04-03 | New notice | $1.8M | $1.8M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1783036.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Biodexa Pharmaceuticals Plc | Bio & Health | $6.8M |
| 2 | Entera Bio Ltd. | Bio & Health | $6.6M |
| 3 | Meihua International Medical Technologies Co., Ltd. rookie | Bio & Health | $5.6M |
| 4 | Medicus Pharma Ltd. | Bio & Health | $5.2M |
| 5 | Biodexa Pharmaceuticals Plc | Bio & Health | $5M |
| 6 | ASLAN Pharmaceuticals Ltd | Bio & Health | $5M |